BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23821426)

  • 1. [Globoid cell leukodystrophy of adult. A first case in Poland].
    Jastrzębski K; Czartoryska B; Klimek A
    Neurol Neurochir Pol; 2013; 47(3):278-82. PubMed ID: 23821426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
    Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
    Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
    Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
    Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease.
    Lim SM; Choi BO; Oh SI; Choi WJ; Oh KW; Nahm M; Xue Y; Choi JH; Choi JY; Kim YE; Chung KW; Fu XD; Ki CS; Kim SH
    Oncotarget; 2016 Nov; 7(46):74496-74509. PubMed ID: 27780934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
    Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
    Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krabbe disease: an overview.
    Pastores GM
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S75-81. PubMed ID: 20040316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
    Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
    Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine, canine and non-human primate models of Krabbe disease.
    Wenger DA
    Mol Med Today; 2000 Nov; 6(11):449-51. PubMed ID: 11074371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
    Igisu H; Suzuki K
    Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krabbe disease: New hope for an old disease.
    Bradbury AM; Bongarzone ER; Sands MS
    Neurosci Lett; 2021 May; 752():135841. PubMed ID: 33766733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.
    Zhuang S; Kong L; Li C; Chen L; Zhang T
    BMC Neurol; 2019 Jun; 19(1):122. PubMed ID: 31185936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosynthase mediated synthesis of psychosine.
    Goddard-Borger ED; Tysoe C; Withers SG
    Carbohydr Res; 2016 Nov; 435():97-99. PubMed ID: 27721144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
    Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
    Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice.
    Favret J; Nawaz MH; Patel M; Khaledi H; Gelb M; Shin D
    Mol Ther; 2024 Jul; 32(7):2207-2222. PubMed ID: 38734898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krabbe disease: a galactosylsphingosine (psychosine) lipidosis.
    Svennerholm L; Vanier MT; Månsson JE
    J Lipid Res; 1980 Jan; 21(1):53-64. PubMed ID: 7354254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globoid cell leukodystrophy: a family with both late-infantile and adult type.
    Verdru P; Lammens M; Dom R; Van Elsen A; Carton H
    Neurology; 1991 Sep; 41(9):1382-4. PubMed ID: 1891085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy.
    Luddi A; Strazza M; Carbone M; Moretti E; Costantino-Ceccarini E
    Exp Cell Res; 2005 Mar; 304(1):59-68. PubMed ID: 15707574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.